DALLAS, Nov. 13, 2025 (GLOBE NEWSWIRE) -- Instil Bio, Inc. (“Instil”) (Nasdaq: TIL), a clinical-stage biopharmaceutical company focused on developing a pipeline of novel therapies, today reported its ...

Quanterix Corporation (NASDAQ: QTRX), a company transforming healthcare by accelerating biomarker breakthroughs from discovery to diagnostics, today announced financial results for the third quarter ...

ON24 (NYSE: ONTF), a leading intelligent engagement platform for B2B marketing, sales, and other customer-facing teams, today ...

Detailed price information for Acumen Pharmaceuticals Inc (ABOS-Q) from The Globe and Mail including charting and trades.

Edgewise Therapeutics Inc. (Nasdaq: EWTX), a Boulder-based biopharmaceutical company that develops therapies for muscle disease, reported a higher net loss for the third quarter.

BOCA RATON, FL / ACCESS Newswire / November 13, 2025 / Newsmax Inc. (NYSE:NMAX) ("Newsmax" or the "Company") today announced ...

Get the latest insights on Ginkgo Bioworks (DNA) stock: missed Q3 targets, revenue slowdown, rising losses, and investor ...

Q3 2025 Management View Masoud Toloue, President and CEO, stated that "we're pleased with how we executed in the third ...

Q3 2025 Management View CEO Christian Itin reported the launch of AUCATZYL in the U.S. has reached market leadership in ...

Despite a 2025 bear market and falling KPIs, future cash flow stability could mean 34% upside. See here for more on FVRR ...

UroGen Pharma Ltd. (NASDAQ:URGN) is one of the best small-cap biotech stocks to buy according to analysts.

Achieved record gross bookings of $22.8 million and record revenue of $18.7 million Initiated cost-reduction actions expected to lower ...